Delivery Order SPE2DB20D3103-SPE2DB23FN1C5
Award Date
4/18/23
Potential Completion Date
4/19/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the provision of the drug Emgality 120 mg/ml. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,005.44 firm fixed-price contract is for the supply of Emgality, a 120 mg/mL injectable medication, to support military healthcare programs. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,002.72 firm fixed-price delivery order is for the supply of Emgality 120 mg/ml injectable medication and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/mL injectable medication, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/mL injections. The $1,336.96 contract has a performance period through May 10, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,504.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of Emgality 120mg/ml pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any specific business type. This contract is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/mL injectable medication. The $1,671.20 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Emgality 120 mg/ml prescription medication. The contract has a total ceiling value of $1,671.20 and is set to expire on October 8, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,504.08, is a delivery order for the medication Emgality 120 mg/ml. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...